Xarelto Bellwether Loser's New Trial Bid Rejected By Judge

Law360, Los Angeles (December 14, 2017, 8:59 PM EST) -- A Louisiana federal judge on Thursday refused to grant a new trial to a woman who lost a bellwether trial on claims that Janssen Pharmaceuticals’ and Bayer’s blood thinner Xarelto causes internal bleeding, rejecting her contention that a recent scientific study could have changed the jury's mind.

In a seven-page order, U.S. District Judge Eldon E. Fallon denied plaintiff Dora Mingo’s bid for a new trial after a Mississippi federal jury found in August that Johnson & Johnson unit Janssen Pharmaceuticals Inc. and Bayer HealthCare Pharmaceuticals Inc. not were to blame for Mingo’s gastrointestinal bleeding.

Mingo had argued in her motion...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Louisiana Eastern

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Judge

Subscribers Only

Date Filed

December 12, 2014

Law Firms

Companies

Judge Analytics